CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Quinagolide hydrochloride

Last Updated: December 16, 2004
Result type: Reports
Project Number: SR0026-000
Product Line: Reimbursement Review

Generic Name: Quinagolide hydrochloride

Brand Name: Norprolac

Manufacturer: Ferring Pharmaceuticals

Therapeutic Area: Hyperprolactinemia

Indications: Hyperprolactinemia

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: September 28, 2005

Recommendation Type: Do not list